DRRX Past Earnings image   This DRRX past earnings page last updated 11/4/2022
DRRX Past Earnings
PeriodPast Earnings DateGAAP
Q3 202211/2/2022-0.010
Q2 20228/4/2022-0.050
Q1 20225/4/2022-0.050
Q4 20213/7/2022-0.030
Q3 202111/2/2021-0.040
Q2 20217/29/2021-0.040
Q1 20215/4/2021-0.050
Q4 20203/4/2021-0.040
Q3 202011/2/2020-0.050
Q2 20208/3/20200.070
Q1 20205/11/2020-0.050
Q4 20193/3/2020-0.020
Q3 201911/4/2019-0.010
Q2 20198/1/2019-0.040
Q1 20195/7/2019-0.040
Q4 20183/7/2019-0.05
Q3 201811/7/2018-0.02
Q2 20188/1/2018-0.04
Q1 20185/2/2018-0.05
Q4 20173/1/20180.05
Q3 201711/1/2017-0.04
Q2 20178/8/2017-0.07
Q1 20175/10/2017-0.06
Q4 20163/14/2017-0.06
Q3 201610/31/2016-0.06
Q2 20168/1/2016-0.07
Q1 20165/5/2016-0.06
Q4 20152/29/2016-0.05
Q3 201511/2/2015-0.05
Q2 20158/3/2015-0.05
Q1 20154/30/2015-0.04
Q4 20143/2/2015-0.05
Q3 201411/3/2014-0.06
Q2 20148/7/2014-0.05
Q1 20145/1/2014-0.03
Q4 20132/27/2014-0.05
Q3 201311/4/2013-0.06
Q2 20138/5/2013-0.05
Q1 20135/2/2013-0.05
Q4 20122/28/2013-0.06
Q3 201211/5/2012-0.05
Q2 20128/6/2012-0.050
DRRX Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/2/20220.01B
Q2 20228/4/20220.00B
Q1 20225/4/20220.00B
Q4 20213/7/20220.01B
Q3 202111/2/20210.00B
Q2 20217/29/20210.00B
Q1 20215/4/20210.00B
Q4 20203/4/20210.00B
Q3 202011/2/20200.00B
Q2 20208/3/20200.03B
Q1 20205/11/20200.00B
Q4 20193/3/20200.01B
Q3 201911/4/20190.01B
Q2 20198/1/20190.00B
Q1 20195/7/20190.00B
Q4 20183/7/20193.63M
Q3 201811/7/20188.04M
Q2 20188/1/20183.41M
Q1 20185/2/20183.49M
Q4 20173/1/201819.54M
Q3 201711/1/20178.25M
Q2 20178/8/20174.32M
Q1 20175/10/20174.57M
Q4 20163/14/20173.52M
Q3 201610/31/20163.74M
Q2 20168/1/20163.16M
Q1 20165/5/20163.61M
Q4 20152/29/20165.17M
Q3 201511/2/20154.74M
Q2 20158/3/20154.44M
Q1 20154/30/20154.77M
Q4 20143/2/20154.27M
Q3 201411/3/20144.26M
Q2 20148/7/20144.58M
Q1 20145/1/20146.30M
Q4 20132/27/20144.30M
Q3 201311/4/20132.97M
Q2 20138/5/20133.92M
Q1 20135/2/20134.20M
Q4 20122/28/20134.30M
Q3 201211/5/20123.80M
Q2 20128/6/20120.00B
Quotes delayed 20 minutes

Email EnvelopeFree DRRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Durect (DRRX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

DSGN Past Earnings
DTIL Past Earnings
DVA Past Earnings
DVAX Past Earnings
DXCM Past Earnings
DYAI Past Earnings
DYN Past Earnings
EAR Past Earnings
EBS Past Earnings
ECOR Past Earnings

DRRX Past Earnings Q&A

What was the best and worst DRRX past earnings results?
For Durect, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest DRRX past earnings result in our data set was 0.070/share posted in Q2 2020, while the lowest was in Q2 2017 when DRRX posted -0.07/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2020 when DRRX reported 0.03B in revenue, while the quarter with the lowest revenue in our data set was Q1 2022 at 0.00B of revenue.

  Suggested answer: There are 42 DRRX past earnings results in our data set.

On this page we presented the DRRX past earnings date information for Durect. Reviewing that DRRX Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2020, when DRRX posted gaap of 0.070/share. Meanwhile the lowest DRRX past earnings result was in Q2 2017, when DRRX posted gaap of -0.07/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2020 when DRRX reported 0.03B in revenue, while the smallest revenue quarter was Q1 2022 when DRRX reported 0.00B in revenue.

Any self directed investor doing their due diligence on DRRX or any other given stock can benefit from researching all of the Durect past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Durect past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for DRRX. Thanks for visiting, and the next time you need to research DRRX past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Institutional Holders of EMIF, CF Industries Holdings DMA, SCS YTD Return.


DRRX Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.